ZLI:CA:TSX-BMO Low Volatility International Equity ETF (CAD)

ETF | International Equity |

Last Closing

CAD 26.11

Change

-0.22 (-0.84)%

Market Cap

CAD 0.29B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for International Equity

Symbol Name Price(Change) Market Cap
XEF:CA iShares Core MSCI EAFE IMI

-0.08 (-0.21%)

CAD 8.98B
ZEA:CA BMO MSCI EAFE

-0.01 (-0.04%)

CAD 8.66B
XFH:CA iShares Core MSCI EAFE IMI Ind..

+0.13 (+0.40%)

CAD 1.48B
XIN:CA iShares MSCI EAFE (CAD Hedged)

+0.13 (+0.34%)

CAD 1.39B
QDX:CA Mackenzie International Equity..

N/A

CAD 1.00B
ZDM:CA BMO MSCI EAFE (CAD Hedged)

+0.03 (+0.10%)

CAD 0.89B
VEF:CA Vanguard FTSE Developed All Ca..

+0.18 (+0.32%)

CAD 0.64B
FCIQ:CA Fidelity International High Qu..

-0.07 (-0.18%)

CAD 0.60B
HXDM:CA Global X Intl Developed Market..

-0.18 (-0.37%)

CAD 0.58B
ZDI:CA BMO International Dividend Uni..

-0.02 (-0.08%)

CAD 0.46B

ETFs Containing ZLI:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (International Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.36% 17% F 48% F
Dividend Return 2.03% 54% F 48% F
Total Return 12.38% 31% F 49% F
Trailing 12 Months  
Capital Gain 18.90% 37% F 48% F
Dividend Return 2.19% 24% F 39% F
Total Return 21.08% 40% F 48% F
Trailing 5 Years  
Capital Gain 5.20% 6% D- 40% F
Dividend Return 7.13% 19% F 24% F
Total Return 12.33% 3% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain 0.65% N/A N/A 38% F
Dividend Return 1.97% N/A N/A 38% F
Total Return 1.31% N/A N/A 44% F
Risk Return Profile  
Volatility (Standard Deviation) 9.43% N/A N/A 83% B
Risk Adjusted Return 20.88% N/A N/A 42% F
Market Capitalization 0.29B 59% D- 51% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.